Company registration number 03663794 (England and Wales)
NK CHEMICALS (EUROPE) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
NK CHEMICALS (EUROPE) LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 3
NK CHEMICALS (EUROPE) LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Equity
Called up share capital
200
200
Capital redemption reserve
2
2
Retained earnings
(202)
(202)
Total equity
-
0
-
0

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 19 August 2025 and are signed on its behalf by:
Mr N J Copp
Director
Company Registration No. 03663794
NK CHEMICALS (EUROPE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

NK Chemicals (Europe) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Jubilee Way, Grange Moor, Wakefield, West Yorkshire, WF4 4TD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared on the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

The company was dormant throughout the year. true

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

NK CHEMICALS (EUROPE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
-
0
-
0
4
Parent company

The company is 100% owned by:

 

Barentz Finco UK Limited

22a St. James’S Square

London

United Kingdom

SW1Y 4JH

2024-12-312024-01-01falsefalsefalse19 August 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityDr W PieschnickMr Hidde Van der WalMr N J CoppMr A J Litchfield036637942024-01-012024-12-31036637942024-12-3103663794core:ShareCapital2024-12-3103663794core:ShareCapital2023-12-3103663794core:CapitalRedemptionReserve2024-12-3103663794core:CapitalRedemptionReserve2023-12-3103663794core:RetainedEarningsAccumulatedLosses2024-12-3103663794core:RetainedEarningsAccumulatedLosses2023-12-31036637942023-12-3103663794bus:Director32024-01-012024-12-31036637942023-01-012023-12-3103663794bus:PrivateLimitedCompanyLtd2024-01-012024-12-3103663794bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3103663794bus:FRS1022024-01-012024-12-3103663794bus:AuditExemptWithAccountantsReport2024-01-012024-12-3103663794bus:Director12024-01-012024-12-3103663794bus:Director22024-01-012024-12-3103663794bus:Director42024-01-012024-12-3103663794bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP